Work

Synergy is documented in vitro with low-dose recombinant tumor necrosis factor, cisplatin, and doxorubicin in ovarian cancer cells

Year: 1990

Type: article

Source: Gynecologic Oncology

DOI: 10.1016/0090-8258(90)90068-v

Authors: Benjamin Bonavida, Toshiharu Tsuchitani, Jacob Zighelboim, Jonathan S. Berek

Institutions: University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2082069381

FWCI: 3.466

Cites: 17

Cited by: 32

Related to: 10